Ubs Group Ag Organovo Holdings, Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,036 shares of ONVO stock, worth $855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,036
Previous 14,355
85.82%
Holding current value
$855
Previous $10,000
90.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ONVO
# of Institutions
34Shares Held
2.44MCall Options Held
17KPut Options Held
0-
Armistice Capital, LLC New York, NY1.22MShares$511,5600.01% of portfolio
-
Prescott Group Capital Management, L.L.C. Tulsa, OK414KShares$173,8940.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA347KShares$145,9440.0% of portfolio
-
Black Rock Inc. New York, NY142KShares$59,7270.0% of portfolio
-
Geode Capital Management, LLC Boston, MA125KShares$52,7010.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $3.66M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...